日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)

更正:帕博西尼联合内分泌治疗对一线或二线治疗的 HR+/HER2- 晚期乳腺癌日本患者的总生存期:一项多中心观察性研究(P-BRIDGE 研究)

Nagai, Shigenori E; Hattori, Masaya; Yoshinami, Tetsuhiro; Masuda, Hiroko; Okamura, Takuho; Watanabe, Kenichi; Nakayama, Takahiro; Tsuneizumi, Michiko; Takabatake, Daisuke; Harao, Michiko; Yoshino, Hiroshi; Mori, Natsuko; Yasojima, Hiroyuki; Oshiro, Chiya; Iwase, Madoka; Yamaguchi, Miki; Sangai, Takafumi; Sasada, Shinsuke; Ishida, Takanori; Futamura, Manabu; Muramatsu, Yasuaki; Kosaka, Nobuyoshi; Masuda, Norikazu

Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group

日本老年HR+/HER2-晚期乳腺癌患者接受帕博西尼联合内分泌治疗的真实世界疗效:P-BRIDGE研究按年龄分组的亚组分析

Masuda, Hiroko; Nagai, Shigenori E; Hattori, Masaya; Yoshinami, Tetsuhiro; Okamura, Takuho; Watanabe, Kenichi; Nakayama, Takahiro; Tsuneizumi, Michiko; Takabatake, Daisuke; Harao, Michiko; Yoshino, Hiroshi; Mori, Natsuko; Yasojima, Hiroyuki; Oshiro, Chiya; Iwase, Madoka; Yamaguchi, Miki; Sangai, Takafumi; Sasada, Shinsuke; Ishida, Takanori; Futamura, Manabu; Oda, Hirotaka; Muramatsu, Yasuaki; Masuda, Norikazu

Chest Wall Reconstruction and Chemotherapy for Infectious Costochondritis Associated with Recurrent Breast Cancer

胸壁重建和化疗治疗与复发性乳腺癌相关的感染性肋软骨炎

Katayama, Yuki; Sakuragi, Masako; Matsumoto, Mariko; Machinaga, Mitsuki; Ogihara, Kasumi; Fukuda, Takayo; Shiba, Satomi; Kawata, Hirotoshi; Harao, Michiko; Yamaguchi, Hironori

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX 在老年 HER2 阳性早期乳腺癌患者中的应用:曲妥珠单抗±化疗 RESPECT 试验的长期随访结果

Nozawa, Kazuki; Sawaki, Masataka; Uemura, Yukari; Tsuneizumi, Michiko; Takano, Toshimi; Gondo, Naomi; Hara, Fumikata; Harao, Michiko; Toyama, Tatsuya; Taira, Naruto; Vivancos, Ana; Perou, Charles M; Sanfeliu, Esther; Brasó-Maristany, Fara; Parker, Joel S; Buckingham, Wesley; Paré, Laia; Villacampa, Guillermo; Marín-Aguilera, Mercedes; Villagrasa, Patricia; Prat, Aleix; Iwata, Hiroji

Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial

转移性乳腺癌原发肿瘤切除联合全身治疗与单纯全身治疗的疗效比较(JCOG1017,PRIM-BC):一项随机临床试验

Shien, Tadahiko; Hara, Fumikata; Aogi, Kenjiro; Yanagida, Yasuhiro; Tsuneizumi, Michiko; Yamamoto, Naohito; Matsumoto, Hiroshi; Suto, Akihiko; Watanabe, Kenichi; Harao, Michiko; Kanbayashi, Chizuko; Itoh, Mitsuya; Kadoya, Takayuki; Anan, Keisei; Maeda, Shigeto; Sasaki, Keita; Ogawa, Gakuto; Saji, Shigehira; Fukuda, Haruhiko; Iwata, Hiroji

Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)

一线或二线治疗中,帕博西尼联合内分泌治疗对日本 HR+/HER2- 晚期乳腺癌患者的总生存期:一项多中心观察性研究(P-BRIDGE 研究)

Nagai, Shigenori E; Hattori, Masaya; Yoshinami, Tetsuhiro; Masuda, Hiroko; Okamura, Takuho; Watanabe, Kenichi; Nakayama, Takahiro; Tsuneizumi, Michiko; Takabatake, Daisuke; Harao, Michiko; Yoshino, Hiroshi; Mori, Natsuko; Yasojima, Hiroyuki; Oshiro, Chiya; Iwase, Madoka; Yamaguchi, Miki; Sangai, Takafumi; Sasada, Shinsuke; Ishida, Takanori; Futamura, Manabu; Muramatsu, Yasuaki; Kosaka, Nobuyoshi; Masuda, Norikazu

Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus

二甲双胍改变肿瘤免疫微环境,改善患有 2 型糖尿病的乳腺癌患者的预后

Satomi Shiba, Michiko Harao, Akira Saito, Masako Sakuragi, Joji Kitayama, Naohiro Sata

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition

日本乳腺癌学会乳腺癌系统治疗临床实践指南(2022版)

Terada, Mitsuo; Ito, Aki; Kikawa, Yuichiro; Koizumi, Kei; Naito, Yoichi; Shimoi, Tatsunori; Ishihara, Mikiya; Yamanaka, Takashi; Ozaki, Yukinori; Hara, Fumikata; Nakamura, Rikiya; Hattori, Masaya; Miyashita, Minoru; Kondo, Naoto; Yoshinami, Tetsuhiro; Takada, Masahiro; Matsumoto, Koji; Narui, Kazukata; Sasada, Shinsuke; Iwamoto, Takayuki; Hosoda, Mitsuchika; Takano, Yuko; Oba, Takaaki; Sakai, Hitomi; Murakami, Akari; Higuchi, Toru; Tsuchida, Junko; Tanabe, Yuko; Shigechi, Tomoko; Tokuda, Emi; Harao, Michiko; Kashiwagi, Shinichiro; Mase, Junichi; Watanabe, Junichiro; Nagai, Shigenori E; Yamauchi, Chikako; Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira; Toyama, Tatsuya

Making the upper edge of a silicone breast implant invisible by fat onlay-grafting harvested from the affected inframammary fold

通过从受影响的乳房下皱襞提取脂肪进行脂肪移植,使硅胶乳房假体的上边缘隐形。

Ishii, Naohiro; Harao, Michiko; Kiuchi, Tomoki; Sakai, Shigeki; Uno, Takahiro; Ando, Jiro; Kishi, Kazuo

4-1BB-Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells

4-1BB 增强三阴性乳腺癌 CD8+ TIL 扩增揭示突变特异性 CD8+ T 细胞

Michiko Harao, Marie-Andrée Forget, Jason Roszik, Hui Gao, Gildy V Babiera, Savitri Krishnamurthy, Jessica A Chacon, Shumin Li, Elizabeth A Mittendorf, Sarah M DeSnyder, Korrene F Rockwood, Chantale Bernatchez, Naoto T Ueno, Laszlo G Radvanyi, Luis Vence, Cara Haymaker, James M Reuben